Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial - Roblin, X; Boschetti, G; Williet, N (Alimentary pharmacology & therapeutics, 2017)
. doi:10.1111/apt.14106